Keith O. Elliston, PhD is an experienced scientist and entrepreneur with expertise in the development and growth of new life science and technology businesses, from both operational and investment perspectives. As a scientist, Keith specializes in Systems Biology; he built and managed the Systems Biology program for CHDI, the Huntington's Disease foundation, and has been a co-founder and Chief Scientist for the tranSMART Foundation, and has more than 40 peer reviewed scientific publications. As an entrepreneur, Keith is a co-founder and CEO for Virtual-Rx, a virtual pharma platform company, was Co- founder, President and CEO, of Selventa (nee' Genstruct), a venture-backed systems biology platform company, and CEO and co-founder of Viaken Systems, a venture-backed informatics service provider, among others. Keith began his career at Merck, where he built and led the Bioinformatics and Genomics programs, and ran the Merck Gene Index, a privately funded public genome effort that published the first sequence for 90% of expressed human genes. Keith has successfully built biotechnology businesses from startup through IPO, and established profitable and capital efficient companies working both with Venture Capital and as a founder or advisor. Keith combines extensive experience in pharmaceutical R&D, biotechnology and information technology, with successful executive and team leadership into a unique set of skills that drives innovation and value.

Current Status:

• President - Seneca Creek Research, Inc.
• Chief Scientist - tranSMART Foundation
• Co-founder & CEO - Virtual-Rx, LLC